Janssen Pharmaceutica NV

Beerse  |  Group Patron

R&D and manufacturing of pharmaceutical products for human use, as well as preservation and material protection products.

Member news

Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidate; Phase 1/2a Clinical Trial to Begin in Second Half of July

Janssen starts production of disinfectant hand liquid to fill hospital shortages in the fight against the corona virus

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with US Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use